Can Patients With Relapsed, Previously Untreated, Stage I Epithelial Ovarian Cancer Be Successfully Treated With Salvage Therapy?
Désirée Kolomainen(Royal Marsden NHS Foundation Trust), Martin Gore(Imperial College London), Roger A’Hern, Cyril Fisher(Royal Marsden Hospital), David M. King(Royal Marsden Hospital), Fareeda Y. Coxon(Newcastle upon Tyne Hospitals NHS Foundation Trust), John H. Shepherd(Royal Marsden Hospital), Desmond P.J. Barton(NIHR Biomedical Research Centre at The Royal Marsden and the ICR), Stanley B. Kaye(Royal Marsden Hospital), Peter Blake(Boston University)
Cited by 34
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850